This article is more than 5 years old. Information may no longer be current.
Age a factor in iris color changes from latanoprost use, study finds
Click Here to Manage Email Alerts
Age appears to be an important risk factor influencing changes in iris pigmentation resulting from latanoprost use, a prospective study suggests.
Esther Arranz-Marquez, MD, PhD, and colleague Miguel A. Teus, MD, PhD, compared the incidence of iris color change between two groups of 36 patients with primary open-angle glaucoma. The first group included patients younger than 60 years; the second group included patients older than 75 years.
The researchers obtained photographs of both irides of each patient before beginning unilateral treatment with Xalatan (latanoprost, Pfizer) and again at 6 months follow-up. They found that eight patients (22.22%) in the first group and 28 patients (77.78%) in the second group developed an increase in iris pigmentation (P = .0001), according to the study.
Both groups were matched in basal iris colors at baseline, the authors noted.
The study is published in the July issue of American Journal of Ophthalmology.